Skip to main content
. 2021 Sep 22;13(10):1538. doi: 10.3390/pharmaceutics13101538
ApoE apolipoprotein E
BBB blood brain barrier
BN bombesin
BTZ bortezomib
CPE cell-penetration enhancer
CUR curcumin
CD cyclodextrin
DC dendritic cell
DDS drug delivery system
DEX dextran
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
DOX doxorubicin
DPPE 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
DSPE 1,2-distearoyl-sn-glycero-3-phosphoethanolamine
DTX docetaxel
EDAC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
EGFR epidermal growth factor receptor
EPR enhanced permeability and retention
FA folic acid
FR folate receptor
5-FU 5-fluorouracil
FZD10 frizzled 10 protein
GEM gemcitabine
HA hyaluronic acid
HEGFR human epidermal growth factor receptor
HPβ-CD 2-(hydroxypropyl)-β-cyclodextrin
INS insulin
Lf lactoferrin
mAb(s) monoclonal antibody(ies)
MDR multidrug resistance
MTX methotrexate
NB(s) nanobubble(s)
NP(s) nanoparticle(s)
PCL poly(ε-caprolactone)
PDAC pancreatic adenocarcinoma
PEG polyethylene glycol
PEI polyethyleneimine
PLGA poly lactic-co-glycolic acid
PLA poly lactic acid
PSMA prostate-specific membrane antigen
PTX paclitaxel
SLN(s) solid lipid nanoparticle(s)
SQ squalene
SVA(s) supramolecular vesicular aggregate(s)
T3 thyroid hormone triiodothyronine
Tf transferrin
TfR Tf receptor
TSH thyroid-stimulating hormone
US ultrasounds
UT urotensin-II
VLDL very low-density lipoprotein